Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ventas Inc (VTR)

Ventas Inc (VTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,733,372
  • Shares Outstanding, K 399,718
  • Annual Sales, $ 3,828 M
  • Annual Income, $ 49,010 K
  • 60-Month Beta 1.21
  • Price/Sales 5.10
  • Price/Cash Flow 17.86
  • Price/Book 2.02
Trade VTR with:

Options Overview Details

View History
  • Implied Volatility 27.54% ( -0.14%)
  • Historical Volatility 22.70%
  • IV Percentile 25%
  • IV Rank 18.14%
  • IV High 47.41% on 10/11/22
  • IV Low 23.14% on 08/12/22
  • Put/Call Vol Ratio 0.63
  • Today's Volume 2,048
  • Volume Avg (30-Day) 1,106
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 26,445
  • Open Int (30-Day) 28,123

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.72
  • Number of Estimates 8
  • High Estimate 0.73
  • Low Estimate 0.71
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -1.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.27 +8.95%
on 01/10/23
53.15 -3.10%
on 02/02/23
+3.68 (+7.70%)
since 01/06/23
3-Month
40.91 +25.89%
on 11/08/22
53.15 -3.10%
on 02/02/23
+10.89 (+26.82%)
since 11/07/22
52-Week
35.33 +45.77%
on 10/13/22
64.02 -19.56%
on 03/29/22
+0.90 (+1.78%)
since 02/07/22

Most Recent Stories

More News
Ventas (VTR) to Report Q4 Earnings: What's in the Cards?

Ventas' (VTR) Q4 earnings are likely to have benefited from the occupancy growth in the SHOP segment. However, higher interest rates and a stronger U.S. dollar might have been a spoilsport.

PSA : 302.03 (-1.86%)
VTR : 51.50 (-0.71%)
SBAC : 293.13 (-0.89%)
EXR : 167.65 (-0.20%)
What's in Store for Healthpeak (PEAK) This Earnings Season?

High demand for Healthpeak's (PEAK) life-science assets and rising healthcare spending by senior citizens are likely to have aided its Q4 earnings. Interest rate hikes might have been a deterrent.

PSA : 302.03 (-1.86%)
VTR : 51.50 (-0.71%)
EXR : 167.65 (-0.20%)
PEAK : 27.23 (-0.69%)
Omega Healthcare (OHI) to Post Q4 Earnings: What's in Store?

Rent defaults by some of Omega Healthcare's (OHI) operators facing occupancy and elevated staffing cost pressure, and the firm's restructuring moves might have adversely impacted its Q4 earnings.

VTR : 51.50 (-0.71%)
HIW : 29.84 (-0.50%)
OHI : 27.89 (-2.41%)
STAG : 36.40 (+0.14%)
Ventas Appoints J. Justin Hutchens, Executive Vice President, Senior Housing, to Additional Role of Chief Investment Officer

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that J. Justin Hutchens, Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment...

VTR : 51.50 (-0.71%)
PEAK : 27.23 (-0.69%)
NHI : 57.05 (-1.50%)
Ventas Announces Fourth Quarter 2022 Earnings Release Date and Conference Call

Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2022 earnings release after the close of trading on the New York Stock Exchange on Thursday, February 9, 2023. A conference call to discuss those...

VTR : 51.50 (-0.71%)
Ventas Announces Tax Treatment Of 2022 Distributions

Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2022 distributions on the Company’s common stock.

VTR : 51.50 (-0.71%)
Ardent Health Services partners with SwitchPoint Ventures to launch healthcare innovation studio

Ardent Health Services has partnered with SwitchPoint Ventures to launch an innovation studio focused on transforming healthcare delivery and administration. The partnership is an outgrowth of the companies’...

VTR : 51.50 (-0.71%)
Cadence and Ardent Health Services Launch Remote Care Management Program to Improve Care and Outcomes for Patients Outside of Clinics

Cadence today announced a partnership with Ardent Health Services to implement a remote patient monitoring and responsive virtual care program across Ardent’s operations, which include 30 hospitals...

VTR : 51.50 (-0.71%)
Ardent appoints Brad Hoyt, MD chief medical information officer

Ardent Health Services has appointed Brad Hoyt, MD, as chief medical information officer (CMIO). In the new role, Dr. Hoyt will be part of Ardent’s senior leadership team and lead the development and...

VTR : 51.50 (-0.71%)
Is It Wise to Retain Ventas (VTR) Stock in Your Portfolio?

A rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet bode well for Ventas (VTR). Meanwhile, stiff competition and higher interest rates...

VTR : 51.50 (-0.71%)
LAMR : 109.01 (+0.89%)
VICI : 34.55 (-0.29%)
SVC : 8.68 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Ventas, Inc. is a healthcare real estate investment trust (REIT), engaged in acquisition, ownership and leasing of senior housing, life science, research & innovation (R&I) and healthcare properties. It has portfolios of more than 1,200 properties located in the U.S., Canada and the U.K., including senior...

See More

Key Turning Points

3rd Resistance Point 52.93
2nd Resistance Point 52.47
1st Resistance Point 51.98
Last Price 51.50
1st Support Level 51.03
2nd Support Level 50.57
3rd Support Level 50.08

See More

52-Week High 64.02
Fibonacci 61.8% 53.06
Last Price 51.50
Fibonacci 50% 49.67
Fibonacci 38.2% 46.29
52-Week Low 35.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar